New Version of CRISPR Corrects RNA Defects Linked to Huntington’s, ALS

News   Aug 15, 2017 | Original story from University of California, San Diego

 
New Version of CRISPR Corrects RNA Defects Linked to Huntington’s, ALS

These are muscle cells from a patient with myotonic dystrophy type I, untreated (left) and treated with the RNA-targeting Cas9 system (right). The MBNL1 protein is in green, repetitive RNA in red and the cell’s nucleus in blue. MBNL1 is an important RNA-binding protein and its normal function is disrupted when it binds repetitive RNA. In the treated cells on the right, MBNL1 is released from the repetitive RNA. Credit: UCSD

 
 
 

RELATED ARTICLES

APC Protein Deletion Disrupts Cell Signalling and Could Cause Autism

News

Researchers show deletion of the protein APC in progenitor cells leads to massive disruption of brain development and a signaling cascade previously linked to genes associated with autism.

READ MORE

How do Poison Frogs Protect Themselves Against Their Own Neurotoxin?

News

Scientists are a step closer to resolving a related head-scratcher, how do these frogs keep from poisoning themselves?

READ MORE

The Ancient Behaviour of Sleep, Conserved Throughout Evolution

News

The finding that jellyfish sleep implies that sleep is an ancient behavior, largely untouched by millennia of evolution.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Genomics Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE